t:slim X2 Insulin Pump for Kids | Tandem Diabetes Care

Tandem Diabetes Care offers two automated insulin delivery systems that are powered by Control-IQ technology, so you can choose the pump that's best for your family.

Impressively Small Tandem Mobi System

Tandem Mobi can be worn almost anywhere,* giving kids and teens more options for how they manage their diabetes. Plus, it's controlled with a compatible, personal iPhone,^† so it can fit into their lifestyle.

Learn More

Color Touchscreen t:slim X2 Insulin Pump

The t:slim X2 insulin pump helps keep diabetes under control, offering more freedom for kids and greater peace of mind for their parents. It integrates into everyday life like any modern device.

Learn More

Real families, real results.

Better Sleep for the Whole Family

80% overnight sensor time in range for participants aged 6-13 while using Control‑IQ technology.¹

Immediate Outcomes

Control-IQ technology study participants saw a 13% improvement in time in range within the first day.²

Note: As tested on the t:slim X2 insulin pump with Control‑IQ technology and Dexcom G6 CGM.

Tandem pumps are powered by Control-IQ technology

The Control-IQ technology algorithm predicts and helps prevent highs and lows by using CGM values^‡ to predict glucose levels 30 minutes ahead and automatically adjust insulin delivery every five minutes and automatic correction boluses,^§ up to one per hour.

What Kids and Caregivers are Saying

Hear from other kids and caregivers who have experienced the life‑changing benefits of Tandem automated insulin delivery.

I love that the automatic correction bolus can help him out. It helps us out too.

Maria

Mom to Jarim

We sleep at night. That's humongous. Tandem and Control-IQ technology take so much stress off of our plate.

Kim

Mom to Anna

If my pump is tucked away while we're riding, I can get the information I need right on my phone.

Everett

diagnosed 2021

She is in range and has a 'partner' with her diabetes management as the pump is integrated with her Dexcom and helps treat highs and lows.

Jocelyn

Mom to Tessa

If I'm performing, I don't have to worry about going low. And if I'm at church or wearing a dress, I can just go to my phone to bolus.

Eva

diagnosed 2015

I like that Tandem Mobi is tiny. It doesn't get caught on anything. It's light and easy to carry around.

Marissa

diagnosed 2020

Infusion Sets

Choose from a variety of cannula materials, tubing lengths, and insertion angles to fit your needs.

View Options

CGM Options

Tandem insulin pumps integrate with multiple CGM sensors, giving kids & teens choices for managing diabetes.

See Options

Activity Settings

Includes optional activity settings for sleep and exercise that adjust the range of treatment values.

Learn More

Learn more about the powerful systems that are ideal for families.

First Name

Last Name

Email Address

Phone Number

Zip or Postal Code

Consent

Responsible Use of Control‑IQ Technology

Even with advanced systems such as Control-IQ technology, you are still responsible for actively managing your diabetes. Control-IQ technology does not prevent all high and low blood glucose events. The system is designed to help reduce glucose variability, but it requires your accurate input of information, such as meals and periods of sleep or exercise. Control-IQ technology will not function as intended unless you use all system components, including your CGM, infusion sets and pump cartridges, as instructed. Importantly, the system cannot adjust your insulin dosing if the pump is not receiving CGM readings. Because there are situations and emergencies that the system may not be capable of identifying or addressing, always pay attention to your symptoms and treat according to your healthcare provider’s recommendations.

* Do not wear or place your pump more than 12 inches above your infusion site. Doing so may result in over delivery of insulin.

† The mobile app requires a compatible iPhone model and operating system (sold separately). Only available to pump users who reside in the United States.

‡ CGM sold separately.

§ If glucose values are predicted to be above 180 mg/dL, Control-IQ technology calculates a correction bolus using the Personal Profile settings and a target of 110 mg/dL and delivers 60% of that value.

References

1. Breton MD, Kanapka L, Beck RW, et al. A randomized trial of closed-loop control in children with type 1 diabetes. N Engl J Med. 2020;383:836-845. doi: 10.1056/ NEJMoa2004736.

2. Beck RW, Kanapka LG, Breton MD, et al. A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ technology in Youth and Adults from Age 2 to 72. Diabetes Technol Ther. 2023;25(5):329-342. doi: 10.1089/dia.2022.0558.

Important Safety Information

RX ONLY.

Indications for Use

Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is intended for single patient, home use and requires a prescription. The pump is indicated for use in individuals 6 years of age and greater.

t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is intended for single patient use. The pump is indicated for use with NovoLog or Humalog U-100 insulin. The pump is indicated for use in individuals 6 years of age and greater.

Control-IQ technology: Control-IQ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons 6 years of age and greater. Control-IQ technology is intended for single patient use. Control-IQ technology is indicated for use with NovoLog or Humalog U-100 insulin.

Warning: Control-IQ technology should not be used by anyone under the age of 6 years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.

Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of a Tandem insulin pump and Control-IQ technology must use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The Tandem pump must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.

Insulin Pumps for Kids and Teens #1 Recommended pump brand by people living with diabetes

Impressively Small Tandem Mobi System

Color Touchscreen t:slim X2 Insulin Pump

Real families, real results.

Tandem pumps are powered by Control-IQ technology

What Kids and Caregivers are Saying

Infusion Sets

CGM Options

Activity Settings

Learn more about the powerful systems that are ideal for families.

Positively Different

Connected Care

Disclosures